Literature DB >> 6339385

Characterization of the murine immune response to type 6 pneumococcal polysaccharide.

R L Fairchild, H Braley-Mullen.   

Abstract

The antibody response to type 6 (Danish type 6A) pneumococcal capsular polysaccharide (S6) was determined in various strains of mice. S6 elicited a very low plaque-forming cell (PFC) response in most strains of mice. BALB/c mice responded better than most other strains, and the response to S6 was further characterized in BALB/c mice. Immunization with 1 to 5 micrograms of S6 induced a plaque-forming cell response of short duration which consisted totally of immunoglobulin M-producing PFC. Athymic nude mice produced three- to fivefold more PFC in response to S6 than their euthymic littermates, suggesting that thymus-derived (T) cells negatively influence the S6 response. Regulation of the response by T cells was further suggested by the ability of antilymphocyte serum to enhance the S6 PFC response and by the suppressed response induced by priming with a low dose of S6 3 days before immunization with an optimal dose of S6 (low dose paralysis). When concanavalin A was given 2 days after immunization with S6, the response was enhanced two- to sevenfold, suggesting that the response is also positively influenced by T amplifier cells. When the avidity of the antibody produced by S6-specific PFC was measured by a plaque inhibition test, the avidity of the anti-S6 antibody was found to be very low. These results suggest that S6 is a poor immunogen because the affinity of the S6-specific antibody and B cell surface receptors is low.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339385      PMCID: PMC347996          DOI: 10.1128/iai.39.2.615-622.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Evidence for the existence of two functionally distinct types of cells which regulate the antibody response to type 3 pneumococcal polysaccharide.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott; R F Barth
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

2.  Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum.

Authors:  P J Baker; R F Barth; P W Stashak; D F Amsbaugh
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

3.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

4.  Strain differences in the antibody plaque-forming cell responses of inbred mice to pneumococcal polysaccharide.

Authors:  H C Braley; M J Freeman
Journal:  Cell Immunol       Date:  1971-02       Impact factor: 4.868

5.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells.

Authors:  P J Baker; P W Stashak; D F Amsbaugh; B Prescott
Journal:  Immunology       Date:  1971-04       Impact factor: 7.397

6.  Quantitative and qualitative studies on the primary antibody response to pneumococcal polysaccharides at ehe cellular level.

Authors:  P H Baker; P W Stashak
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

7.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells.

Authors:  P J Baker; P W Stashak; B Prescott
Journal:  Appl Microbiol       Date:  1969-03

8.  Studies on the regulation of avidity at the level of the single antibody-forming cell. The effect of antigen dose and time after immunization.

Authors:  B Andersson
Journal:  J Exp Med       Date:  1970-07-01       Impact factor: 14.307

9.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

10.  Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells.

Authors:  P J Baker; N D Reed; P W Stashak; D F Amsbaugh; B Prescott
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307

View more
  8 in total

1.  Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.

Authors:  W T Jansen; S Hogenboom; M J Thijssen; J P Kamerling; J F Vliegenthart; J Verhoef; H Snippe; A F Verheul
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Role of spleen in immune response to polyvalent pneumococcal vaccine.

Authors:  F Di Padova; M Dürig; J Wadström; F Harder
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

3.  Phosphorylcholine determinants in six pneumococcal capsular polysaccharides detected by monoclonal antibody.

Authors:  U B Sørensen; R Agger; J Bennedsen; J Henrichsen
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

4.  Conjugation of polysaccharide 6B from Streptococcus pneumoniae with pneumococcal surface protein A: PspA conformation and its effect on the immune response.

Authors:  Catia T Perciani; Giovana C Barazzone; Cibelly Goulart; Eneas Carvalho; Joaquin Cabrera-Crespo; Viviane M Gonçalves; Luciana C C Leite; Martha M Tanizaki
Journal:  Clin Vaccine Immunol       Date:  2013-04-03

5.  Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.

Authors:  R Schneerson; J B Robbins; C Chu; A Sutton; W Vann; J C Vickers; W T London; B Curfman; M C Hardegree; J Shiloach
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

6.  Primary murine immunoglobulin M responses to certain pneumococcal capsular polysaccharides consist primarily of anti-pneumococcal cell wall carbohydrate antibodies.

Authors:  R L Fairchild; K E Sterner; H Braley-Mullen
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

7.  Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype 11 capsular polysaccharide.

Authors:  J W Zigterman; J E van Dam; H Snippe; F T Rotteveel; M Jansze; J M Willers; J P Kamerling; J F Vliegenthart
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

8.  Natural killer cell regulation of age-related and type-specific variations in antibody responses to pneumococcal polysaccharides.

Authors:  M Khater; J Macai; C Genyea; J Kaplan
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.